Your email has been successfully added to our mailing list.

×
0.00441964285714267 0.00441964285714267 0.0176785714285713 0.0176785714285713 -0.00175000000000016 -0.00875000000000022 -0.000178571428571607 -0.0178571428571431
Stock impact report

CytoDyn Announces Strategy to Complete Development of Novel ProstaGene Gene-based Prostate Cancer Prognostic Test

CYTODYN INC (CYDY) 
NASDAQ:AMEX Investor Relations: ir.cytodyn.com
Company Research Source: GlobeNewswire
VANCOUVER, Washington, Oct. 09, 2018 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), CytoDyn unveils its strategy to complete development of PCaTest, a novel gene-based prognostic test for prostate cancer developed by ProstaGene.  Following the completion of CytoDyn’s previously announced proposed acquisition of assets from ProstaGene, the Company intends to initiate a clinical study designed to further demonstrate the superiority of the PCaTest compared with current genetic tests in predicting outcomes of individuals with prostate cancer.  Study results are expected within four months from the commencement of the clinical study. In August 2018, CytoDyn announced a definitive agreement to acquire substantially all of the assets of ProstaGene.  The closing of the proposed ProstaGene asset acquisition is subject to various closing conditions and is expected to close during the fourth quarter of 2018.      “The PCaTest has shown a three- to four-times superior hazards ratio, the pred Show less Read more
Impact Snapshot
Event Time:
CYDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CYDY alerts
Opt-in for
CYDY alerts

from News Quantified
Opt-in for
CYDY alerts

from News Quantified